{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:21:57Z","timestamp":1787923317687,"version":"build-2784847793"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Germ cell tumor (GCT) patients with unfavourable response to first-line therapy still lack reliable diagnostic and effective treatment Detailed correlation of total extracellular DNA (ecDNA), other DNA species and endogenous DNase levels in GCT patients\u2019 plasma and translational utility remains under- investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Study aim and methods<\/jats:title>\n                    <jats:p>We determined DNase plasma levels, ecDNA of different subcellular origin and neutrophil extracellular trap (NETs)-associated markers. Next, we determined the associations of these parameters with a level of the DNA damage, immune inflammatory index, specific immune cell subpopulations in a cohort of the 117 GCT patients and 19 matched healthy donors (HDs). Moreover, we investigated how exogenous DNase affects antitumor effect of cisplatin in GCT model of cisplatin-resistant embryonal carcinoma NTERA-2 CisR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data demonstrate that high level of ecDNA and low level of DNase in GCT patients\u2019 plasma is associated with significantly worse progression-free survival and overall survival. The level of the plasma ecDNA was five times higher in the GCT patients compared to the HDs. The patients with higher total ecDNA and ncDNA, but not mtDNA, had inferior PFS and OS compared to the patients with lower ecDNA (all p\u2009&lt;\u20090.05). There was an inverse correlation between plasma DNase and ecDNA levels, and between plasma DNase level and clinical outcome. Importantly, combined treatment with cisplatin and human recombinant DNase I delayed growth of the NTERA-2 CisR xenografts and prolonged animal survival. Importantly, Pulmozyme significantly reduced intratumoral microvascular density in our preclinical model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data confirm the association between low plasma DNase activity and worse overall survival for the first time in GCT patients. This study further validated the prognostic value of total ecDNA in GCT patients. More importantly, our preclinical data substantiated beneficial effect of Pulmozyme combination with cisplatin treatment to improve the therapeutic outcome in refractory disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0336190","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:44:48Z","timestamp":1764873888000},"page":"e0336190","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6511-6827","authenticated-orcid":true,"given":"Michal","family":"Mego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Vlkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2897-1477","authenticated-orcid":true,"given":"Katarina","family":"Kalavska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pastorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Cierna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Sestakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Chovanec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Udvorkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kucerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Celec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"11","key":"pone.0336190.ref001","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","article-title":"Treatment of testicular cancer: a new and improved model","volume":"8","author":"LH Einhorn","year":"1990","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0336190.ref002","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<848::AID-IJC29>3.0.CO;2-#","article-title":"Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German testicular cancer study group (GTCSG)","volume":"83","author":"C Bokemeyer","year":"1999","journal-title":"Int J Cancer"},{"issue":"12","key":"pone.0336190.ref003","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2000.18.12.2413","article-title":"Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer","volume":"18","author":"RJ Motzer","year":"2000","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0336190.ref004","first-page":"497","article-title":"Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study","volume":"52","author":"J Mardiak","year":"2005","journal-title":"Neoplasma"},{"issue":"5","key":"pone.0336190.ref005","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J","article-title":"Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)","volume":"67","author":"RJ Motzer","year":"1991","journal-title":"Cancer"},{"issue":"27","key":"pone.0336190.ref006","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","article-title":"Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors","volume":"23","author":"GV Kondagunta","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0336190.ref007","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/cancers12061601","article-title":"Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives","volume":"12","author":"J Lobo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0336190.ref008","first-page":"167","article-title":"Testicular cancer in 2023: Current status and recent progress","volume":"74","author":"DJ McHugh","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"pone.0336190.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316872","article-title":"Biomarkers for salvage therapy in testicular germ cell tumors","volume":"24","author":"M Urbini","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"47","key":"pone.0336190.ref010","doi-asserted-by":"crossref","first-page":"18761","DOI":"10.1073\/pnas.1313995110","article-title":"Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing","volume":"110","author":"KCA Chan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pone.0336190.ref011","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa2304714","article-title":"A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening","volume":"390","author":"DC Chung","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0336190.ref012","first-page":"100259","article-title":"Circulating cell-free DNA for cancer early detection","volume":"3","author":"Q Gao","year":"2022","journal-title":"Innovation (Camb)"},{"key":"pone.0336190.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.10.029","article-title":"Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients","volume":"88","author":"S Valpione","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"pone.0336190.ref014","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13058-019-1235-8","article-title":"Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer","volume":"21","author":"D Fernandez-Garcia","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"8","key":"pone.0336190.ref015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"A Kustanovich","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"pone.0336190.ref016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1615\/CritRevOncog.v18.i1-2.90","article-title":"Biological role of cell-free nucleic acids in cancer: the theory of genometastasis","volume":"18","author":"DC Garc\u00eda-Olmo","year":"2013","journal-title":"Crit Rev Oncog"},{"issue":"11","key":"pone.0336190.ref017","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.3390\/biomedicines10112853","article-title":"Cell-free DNA in the pathogenesis and therapy of non-infectious inflammations and tumors","volume":"10","author":"G M\u0171zes","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"pone.0336190.ref018","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1101\/gr.242719.118","article-title":"Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin","volume":"29","author":"K Sun","year":"2019","journal-title":"Genome Res"},{"key":"pone.0336190.ref019","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2017.12","article-title":"Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases","volume":"20","author":"P Celec","year":"2018","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"pone.0336190.ref020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics","volume":"61","author":"V Mutua","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5663","key":"pone.0336190.ref021","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"V Brinkmann","year":"2004","journal-title":"Science"},{"issue":"3","key":"pone.0336190.ref022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031257","article-title":"Neutrophils, cancer and thrombosis: the new Bermuda triangle in cancer research","volume":"23","author":"M Langiu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"36","key":"pone.0336190.ref023","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"TA Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0336190.ref024","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","article-title":"The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis","volume":"11","author":"MT Masucci","year":"2020","journal-title":"Front Immunol"},{"issue":"361","key":"pone.0336190.ref025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1711","article-title":"Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps","volume":"8","author":"J Park","year":"2016","journal-title":"Sci Transl Med"},{"key":"pone.0336190.ref026","doi-asserted-by":"crossref","first-page":"869706","DOI":"10.3389\/fonc.2022.869706","article-title":"Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies","volume":"12","author":"M Mamtimin","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"pone.0336190.ref027","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.trecan.2024.03.007","article-title":"NETscape or NEThance: tailoring anti-cancer therapy","volume":"10","author":"A Mousset","year":"2024","journal-title":"Trends Cancer"},{"issue":"22","key":"pone.0336190.ref028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212246","article-title":"Role of cell-free DNA and deoxyribonucleases in tumor progression","volume":"22","author":"L Alekseeva","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"17","key":"pone.0336190.ref029","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174495","article-title":"Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis","volume":"13","author":"U Demkow","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"pone.0336190.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010238","article-title":"Hold on or cut? Integrin- and MMP-mediated cell-matrix interactions in the tumor microenvironment","volume":"22","author":"S Niland","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0336190.ref031","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12672-024-01010-3","article-title":"Targeting neutrophil elastase is a promising direction for future cancer treatment","volume":"15","author":"W Jia","year":"2024","journal-title":"Discov Oncol"},{"issue":"7","key":"pone.0336190.ref032","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071036","article-title":"Deoxyribonucleases and their applications in biomedicine","volume":"10","author":"L Laukova","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"pone.0336190.ref033","doi-asserted-by":"crossref","DOI":"10.1002\/jbio.201800351","article-title":"Optical sensor revealed abnormal nuclease spatial activity on cancer cell membrane","volume":"12","author":"Y Wang","year":"2019","journal-title":"J Biophotonics"},{"issue":"9","key":"pone.0336190.ref034","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/1097-0142(19880501)61:9<1838::AID-CNCR2820610920>3.0.CO;2-R","article-title":"Variations in serum alkaline DNase activity. A new means for therapeutic monitoring of malignant lymphomas","volume":"61","author":"A Economidou-Karaoglou","year":"1988","journal-title":"Cancer"},{"key":"pone.0336190.ref035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1196\/annals.1368.026","article-title":"Circulating DNA and DNase activity in human blood","volume":"1075","author":"SN Tamkovich","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"pone.0336190.ref036","first-page":"488","article-title":"Blood deoxyribonuclease activity in health and diseases","volume":"53","author":"AV Cherepanova","year":"2007","journal-title":"Biomed Khim"},{"issue":"4","key":"pone.0336190.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky083","article-title":"Deoxyribonuclease I Activity, Cell-Free DNA, and Risk of Liver Cancer in a Prospective Cohort","volume":"2","author":"RM Golonka","year":"2018","journal-title":"JNCI Cancer Spectrum"},{"key":"pone.0336190.ref038","doi-asserted-by":"crossref","first-page":"1171065","DOI":"10.3389\/fimmu.2023.1171065","article-title":"Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro","volume":"14","author":"R Herranz","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0336190.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.03.008","article-title":"Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation","volume":"41","author":"A Mousset","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"pone.0336190.ref040","first-page":"596","article-title":"Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer\u2011associated fibroblasts","volume":"56","author":"S Takesue","year":"2020","journal-title":"Int J Oncol"},{"key":"pone.0336190.ref041","doi-asserted-by":"crossref","first-page":"110846","DOI":"10.1016\/j.intimp.2023.110846","article-title":"DNase based therapeutic approaches for the treatment of NETosis related inflammatory diseases","volume":"124","author":"R Yadav","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"21","key":"pone.0336190.ref042","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.3390\/cancers13215333","article-title":"Neutrophils Extracellular Traps Inhibition Improves PD-1 Blockade Immunotherapy in Colorectal Cancer","volume":"13","author":"H Zhang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"21","key":"pone.0336190.ref043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222112074","article-title":"Human recombinant DNase I (Pulmozyme((R))) inhibits lung metastases in murine metastatic B16 melanoma model that correlates with restoration of the DNase activity and the decrease SINE\/LINE and c-Myc fragments in blood cell-free DNA","volume":"22","author":"L Alekseeva","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0336190.ref044","doi-asserted-by":"crossref","DOI":"10.1177\/1534735416631102","article-title":"Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model","volume":"15","author":"C Trejo-Becerril","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"pone.0336190.ref045","doi-asserted-by":"crossref","first-page":"1149432","DOI":"10.3389\/fonc.2023.1149432","article-title":"Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours","volume":"13","author":"P Lesko","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0336190.ref046","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity","volume":"166","author":"V Sisirak","year":"2016","journal-title":"Cell"},{"issue":"17","key":"pone.0336190.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174163","article-title":"Sex, Age, and Bodyweight as Determinants of Extracellular DNA in the Plasma of Mice: A Cross-Sectional Study","volume":"20","author":"L Janovicova","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"16","key":"pone.0336190.ref048","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3726","article-title":"Isolation and Quantification of Extracellular DNA from Biofluids","volume":"10","author":"\u013d Janovi\u010dov\u00e1","year":"2020","journal-title":"Bio Protoc"},{"issue":"3","key":"pone.0336190.ref049","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/clinchem\/39.3.448","article-title":"Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method","volume":"39","author":"D Nadano","year":"1993","journal-title":"Clin Chem"},{"issue":"46","key":"pone.0336190.ref050","doi-asserted-by":"crossref","first-page":"75996","DOI":"10.18632\/oncotarget.12515","article-title":"The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-na\u00efve patients with germ cell cancer","volume":"7","author":"Z Sestakova","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0336190.ref051","doi-asserted-by":"crossref","first-page":"503200","DOI":"10.1016\/j.mrgentox.2020.503200","article-title":"DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients","author":"Z Sestakova","year":"2020","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"6","key":"pone.0336190.ref052","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.2017.460","article-title":"Systemic immune-inflammation index in germ-cell tumours","volume":"118","author":"M Chovanec","year":"2018","journal-title":"Br J Cancer"},{"key":"pone.0336190.ref053","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fonc.2020.01325","article-title":"Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy","volume":"10","author":"MC Cursano","year":"2020","journal-title":"Front Oncol"},{"issue":"5","key":"pone.0336190.ref054","first-page":"678","article-title":"Detection of Specific Immune Cell Subpopulation Changes Associated with Systemic Immune Inflammation-Index Level in Germ Cell Tumors","volume":"12","author":"K Kalavska","year":"2022","journal-title":"Life (Basel)"},{"issue":"9","key":"pone.0336190.ref055","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/cancers11091224","article-title":"Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells","volume":"11","author":"S Schmidtova","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"pone.0336190.ref056","doi-asserted-by":"crossref","DOI":"10.1097\/00005373-200004000-00003","article-title":"Major trauma enhances store-operated calcium influx in human neutrophils","volume":"48","author":"CJ Hauser","year":"2000","journal-title":"J Trauma"},{"key":"pone.0336190.ref057","doi-asserted-by":"crossref","first-page":"956451","DOI":"10.3389\/fonc.2022.956451","article-title":"Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT","volume":"12","author":"C-R Guo","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0336190.ref058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma","volume":"324","author":"N Weidner","year":"1991","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0336190.ref059","first-page":"1141","article-title":"Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer","author":"ME Van Hoef","year":"1993","journal-title":"Eur J Cancer"},{"key":"pone.0336190.ref060","unstructured":"Hintze JNN. www.ncss.com."},{"key":"pone.0336190.ref061","unstructured":"Genkin DT, Tets G. Method for treating oncological diseases. 2005. https:\/\/doi.org\/WO-2005004903-A1"},{"key":"pone.0336190.ref062","article-title":"Method to improve safety and efficacy of anti-cancer therapy","author":"DT Genkin","year":"2020"},{"issue":"1","key":"pone.0336190.ref063","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.08289.x","article-title":"Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker","volume":"104","author":"J Ellinger","year":"2009","journal-title":"BJU Int"},{"issue":"1","key":"pone.0336190.ref064","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.juro.2009.02.106","article-title":"CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer","volume":"182","author":"J Ellinger","year":"2009","journal-title":"J Urol"},{"issue":"1","key":"pone.0336190.ref065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.juro.2008.08.118","article-title":"Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer","volume":"181","author":"J Ellinger","year":"2009","journal-title":"J Urol"},{"key":"pone.0336190.ref066","doi-asserted-by":"crossref","first-page":"17588359221090365","DOI":"10.1177\/17588359221090365","article-title":"The utility of cfDNA in TGCT patient management: a systematic review","volume":"14","author":"J Krasic","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"24","key":"pone.0336190.ref067","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246115","article-title":"The Role of Cell-Free DNA in Cancer Treatment Decision Making","volume":"14","author":"A Telekes","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"pone.0336190.ref068","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13073-021-00898-8","article-title":"Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients","volume":"13","author":"DWY Tsui","year":"2021","journal-title":"Genome Med"},{"issue":"9","key":"pone.0336190.ref069","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.04.021","article-title":"The clinical value of circulating free tumor DNA in testicular germ cell tumor patients","volume":"40","author":"L Boublikova","year":"2022","journal-title":"Urol Oncol"},{"issue":"3","key":"pone.0336190.ref070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2017.01.027","article-title":"Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients","volume":"15","author":"D Svetlovska","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"pone.0336190.ref071","doi-asserted-by":"crossref","first-page":"910087","DOI":"10.3389\/fonc.2022.910087","article-title":"Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer","volume":"12","author":"S Bleve","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"pone.0336190.ref072","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1305535","article-title":"Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling","volume":"6","author":"PJ Siska","year":"2017","journal-title":"Oncoimmunology"},{"key":"pone.0336190.ref073","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtn.2020.01.035","article-title":"Targeting circulating SINEs and LINEs with DNase I provides metastases inhibition in experimental tumor models","volume":"20","author":"LA Alekseeva","year":"2020","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"pone.0336190.ref074","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12935-020-01458-7","article-title":"Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness","volume":"20","author":"S Schmidtova","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"1","key":"pone.0336190.ref075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-023-02941-5","article-title":"Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy","volume":"43","author":"F Meraz-Torres","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"pone.0336190.ref076","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3892\/ol.2022.13512","article-title":"Effect of the PARP inhibitor veliparib on germ cell tumor cell lines","volume":"24","author":"S Schmidtova","year":"2022","journal-title":"Oncol Lett"},{"issue":"1","key":"pone.0336190.ref077","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12964-023-01196-z","article-title":"Neutrophil extracellular traps promote angiogenesis in gastric cancer","volume":"21","author":"S Yang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"6409","key":"pone.0336190.ref078","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"J Albrengues","year":"2018","journal-title":"Science"},{"issue":"1","key":"pone.0336190.ref079","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?","volume":"37","author":"A Al Shoyaib","year":"2019","journal-title":"Pharm Res"},{"issue":"2","key":"pone.0336190.ref080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41416-023-02498-2","article-title":"Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer","volume":"130","author":"H Kikuchi","year":"2024","journal-title":"Br J Cancer"},{"issue":"5","key":"pone.0336190.ref081","article-title":"Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","volume":"134","author":"Y Li","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0336190.ref082","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12964-023-01112-5","article-title":"Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth","volume":"21","author":"J Li","year":"2023","journal-title":"Cell Commun Signal"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0340033","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000}},{"DOI":"10.1371\/journal.pone.0344953","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:38:48Z","timestamp":1771846728000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336190"}},"subtitle":[],"editor":[{"given":"Milad","family":"Khorasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":82,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336190","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}